Algernon Pharmaceuticals Inc – Ordinary Shares – Class A

Algernon Pharmaceuticals Inc is a Canada based clinical stage drug development company focused on the areas of non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). The company has two segments, the development centre of health-related technology in the United States; the other being a Canadian clinical stage pharmaceutical development company focused on drug repurposing.